menu
    • menu

    Company profile for Mustang Bio

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mustang Bio, Inc. (“Mustang”), a Fortress Biotech Company, is a clinical‐stage biopharmaceutical company focused on the development and commercialization of a broad range of proprietary chimeric antigen receptor engineered T cell (CAR T) immunotherapies and gene therapies in areas of unmet need. Mustang aims to acquire rights to these technologies by licensing or otherwise acquiring an ownership interest, to fund researc...
    Mustang Bio, Inc. (“Mustang”), a Fortress Biotech Company, is a clinical‐stage biopharmaceutical company focused on the development and commercialization of a broad range of proprietary chimeric antigen receptor engineered T cell (CAR T) immunotherapies and gene therapies in areas of unmet need. Mustang aims to acquire rights to these technologies by licensing or otherwise acquiring an ownership interest, to fund research and development, and to outlicense or bring the technologies to market. Mustang has partnered with top medical institutions to advance the development of CAR T.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mustang BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    377 Plantation Street • Worcester, MA 01605
    Telephone
    Telephone
    781-652-4500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mustangbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mustangbio
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/mustang_bio?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    U.S. FDA Grants Orphan Drug Designation to Mustang Bio's MB-101
    U.S. FDA Grants Orphan Drug Designation to Mustang Bio's MB-101

    07 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/07/3111023/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-101-IL13Ra2-targeted-CAR-T-cells-to-Treat-Astrocytomas-and-Glioblastoma.html

    GLOBENEWSWIRE
    07 Jul 2025
    Share Share
    Mustang Bio Complies with Nasdaq Capital Market Requirement
    Mustang Bio Complies with Nasdaq Capital Market Requirement

    05 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/05/3037777/0/en/Mustang-Bio-Regains-Compliance-with-Nasdaq-Capital-Market-Requirement.html

    GLOBENEWSWIRE
    05 Mar 2025
    Share Share
    Mustang Bio Announces Sale of Fixed Assets and Exit of Facility
    Mustang Bio Announces Sale of Fixed Assets and Exit of Facility

    27 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/27/3034325/0/en/Mustang-Bio-Announces-Sale-of-Fixed-Assets-and-Exit-of-Facility.html

    GLOBENEWSWIRE
    27 Feb 2025
    Share Share
    Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price
    Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price

    11 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/11/3024607/0/en/Mustang-Bio-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Requirement.html

    GLOBENEWSWIRE
    11 Feb 2025
    Share Share
    Mustang Bio Announces Closing of $8 Million Public Offering
    Mustang Bio Announces Closing of $8 Million Public Offering

    10 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/10/3023401/0/en/Mustang-Bio-Announces-Closing-of-8-Million-Public-Offering.html

    GLOBENEWSWIRE
    10 Feb 2025
    Share Share
    Mustang Bio Announces Pricing of $8 Million Public Offering
    Mustang Bio Announces Pricing of $8 Million Public Offering

    06 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/06/3021896/0/en/Mustang-Bio-Announces-Pricing-of-8-Million-Public-Offering.html

    GLOBENEWSWIRE
    06 Feb 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search